Activated Charcoal Reborn
- 1 January 1985
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 145 (1) , 43-44
- https://doi.org/10.1001/archinte.1985.00360010063005
Abstract
In the JanuaryArchives, Curtis et al1, described their study of the efficacy of ipecac alonevactivated charcoal plus a catharticvthe three together in the treatment of a simulated aspirin tablet overdose. They accounted for 70% of the ingested aspirin dose in the urine of patients following a standard ipecac regimen, compared with 56% in patients receiving activated charcoal. Their results provided another piece of impressive evidence for the efficacy of activated charcoal in treating the overdose patient. The fine, black, fluffy powder of activated charcoal used as an antidote since the 19th century results from the destructive distillation of organic materials, usually wood pulp. Following activation with steam or strong acid, activated charcoal's surface area (1,000 sq m/mL) and electrostatic properties favor binding with most poisons. CLINICAL EXPERIENCE Linden et al2reported on the use of repeated doses of activated charcoal in treating 11This publication has 2 references indexed in Scilit:
- Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdoseArchives of internal medicine (1960), 1984
- Evaluation of Activated Charcoal-Sorbitol Suspension as an AntidoteJournal of Toxicology: Clinical Toxicology, 1982